Jefferies Financial Group Increases Oracle (NYSE:ORCL) Price Target to $170.00

Oracle (NYSE:ORCLGet Free Report) had its price target hoisted by investment analysts at Jefferies Financial Group from $150.00 to $170.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the enterprise software provider’s stock. Jefferies Financial Group’s target price would indicate a potential upside of 8.19% from the company’s current price.

A number of other analysts have also recently weighed in on ORCL. UBS Group increased their price target on shares of Oracle from $160.00 to $175.00 and gave the stock a “buy” rating in a research note on Tuesday. Deutsche Bank Aktiengesellschaft increased their price target on shares of Oracle from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Monday, June 17th. Citigroup reduced their target price on shares of Oracle from $133.00 to $128.00 and set a “neutral” rating for the company in a research note on Monday, June 10th. Mizuho raised their target price on shares of Oracle from $170.00 to $185.00 and gave the stock an “outperform” rating in a research note on Tuesday. Finally, JPMorgan Chase & Co. raised their target price on shares of Oracle from $110.00 to $120.00 in a research note on Monday. Twelve equities research analysts have rated the stock with a hold rating and nineteen have given a buy rating to the stock. According to MarketBeat.com, Oracle currently has a consensus rating of “Moderate Buy” and a consensus target price of $158.68.

Read Our Latest Stock Analysis on ORCL

Oracle Trading Up 0.8 %

Shares of Oracle stock opened at $157.13 on Tuesday. The company has a fifty day simple moving average of $139.16 and a 200-day simple moving average of $129.32. Oracle has a 12-month low of $99.26 and a 12-month high of $160.52. The company has a current ratio of 0.71, a quick ratio of 0.72 and a debt-to-equity ratio of 8.25. The stock has a market cap of $433.03 billion, a price-to-earnings ratio of 42.35, a PEG ratio of 2.56 and a beta of 1.01.

Oracle (NYSE:ORCLGet Free Report) last issued its earnings results on Monday, September 9th. The enterprise software provider reported $1.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.06. The business had revenue of $13.31 billion during the quarter, compared to analysts’ expectations of $13.23 billion. Oracle had a net margin of 19.76% and a return on equity of 223.01%. The company’s revenue for the quarter was up 6.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.95 EPS. On average, equities analysts forecast that Oracle will post 5.02 EPS for the current fiscal year.

Insider Activity

In other news, Chairman Lawrence Joseph Ellison sold 1,125,000 shares of Oracle stock in a transaction that occurred on Monday, July 15th. The shares were sold at an average price of $143.69, for a total transaction of $161,651,250.00. Following the sale, the chairman now owns 1,145,732,353 shares in the company, valued at $164,630,281,802.57. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Leon E. Panetta sold 15,000 shares of Oracle stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $137.89, for a total value of $2,068,350.00. Following the completion of the sale, the director now owns 58,090 shares in the company, valued at $8,010,030.10. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Chairman Lawrence Joseph Ellison sold 1,125,000 shares of Oracle stock in a transaction on Monday, July 15th. The stock was sold at an average price of $143.69, for a total transaction of $161,651,250.00. Following the completion of the sale, the chairman now owns 1,145,732,353 shares of the company’s stock, valued at approximately $164,630,281,802.57. The disclosure for this sale can be found here. Insiders have sold 1,862,500 shares of company stock worth $266,776,624 over the last 90 days. Company insiders own 42.80% of the company’s stock.

Institutional Trading of Oracle

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Fairway Wealth LLC bought a new stake in Oracle during the second quarter valued at $27,000. Westend Capital Management LLC bought a new stake in Oracle during the first quarter valued at $25,000. POM Investment Strategies LLC bought a new stake in Oracle during the second quarter valued at $30,000. Bbjs Financial Advisors LLC bought a new stake in Oracle during the second quarter valued at $35,000. Finally, Tidemark LLC bought a new stake in Oracle during the fourth quarter valued at $29,000. Institutional investors own 42.44% of the company’s stock.

Oracle Company Profile

(Get Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

See Also

Analyst Recommendations for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.